Kurt Adzema
Analyst · Bank of America. Please go ahead
Thanks, Hartmut. Given the continued challenges and uncertainty associated with COVID-19 and the macroeconomic environment, as a management team, we focused on the following three things: the optimization of our cost structure; the leveraging of our existing manufacturing capacity; and cash generation. We are intensely focused on each dollar we spend. We are spending only those dollars where we are confident on the return on capital will be compelling. I am pleased to report the impact of these efforts were evident in the results for the quarter. Please turn to Slide 3. Third quarter revenue of $1.65 billion, was up 4% sequentially and exceeded our outlook of $1.5 billion to $1.6 billion provided in April. This was primarily due to the strength of demand in our communications business driven by IP, optical networking and wireless, including 5G. Q3 non-GAAP gross margin was 8.1%, up from 6.9% in the prior quarter. This improvement was primarily a result of the strong focus on manufacturing efficiencies and lower costs, including medical, the benefit of certain international government subsidies related to maintaining employment levels in those geographies that helped offset some of the inefficiencies due to COVID-19 and higher revenue levels. Q3 non-GAAP operating expenses of $58.7 million were lower, primarily as the result of reduced spending, including travel. Q3 non-GAAP operating margin improved to 4.6%. Q3 non-GAAP other expenses were approximately $4.5 million. This was down approximately $9 million relative to the prior quarter. This was primarily due to a gain of approximately $3.6 million related to deferred compensation assets as a result of the appreciation in the stock market and other financial assets in the third quarter. This compares to a loss of $5.1 million related to those same deferred compensation assets in the second quarter. As a reminder, gains or losses related to deferred compensation assets have no net impact on non-GAAP earnings per share. Deferred compensation gain or losses are equally offset with corresponding increases or decreases in manufacturing and operating expenses. Finally, Q3 non-GAAP fully diluted earnings per share increased to $0.86 as a result of a strong focus on manufacturing efficiencies and lower costs, including medical, the benefit of certain international government subsidies related to maintaining employment levels in those geographies that helped offset some of the inefficiencies due to COVID-19, and higher revenue levels. We continue to focus on leveraging of existing manufacturing capacity to minimize capital expenditures. Gross capital expenditures were approximately $9.7 million in the third quarter. This was lower than prior expectations, partially due to a delay in delivery of some items due to COVID-19, which we now expect to receive in the fourth quarter. Depreciation and amortization was approximately $28.9 million in the third quarter. Please turn to Slide 4. Here you can see additional income statement details related to the quarter and the associated comparisons. Now please turn to Slide 5. Here you can see, through our efforts to optimize our cost structure, improve our manufacturing efficiency, we delivered non-GAAP margins and earnings per share in the third quarter comparable to our results prior to COVID-19 on lower revenue levels. Now please turn to Slide 6. Here you can see both of our segments’ revenues and gross margins improved relative to the prior quarter. As you can see on the left, IMS segment revenue increased to approximately $1.35 billion. This was primarily due to strength of our communications business driven by IP, optical networks and wireless, including 5G. Non-GAAP gross margins for IMS improved to 7%. On the right, Component Products and Services revenues increased to $337 million, primarily driven by the strength in our printed circuit board and our global services businesses. Non-GAAP gross margin for CPS improved 12%. Now, please turn to Slide 7. On this page, you can see our revenues by end market. As we mentioned, we experienced strong growth in the communications market, which grew 19% over the prior quarter, again driven by IP, optical networks and wireless, including 5G. Medical revenue, driven by COVID-related products, as well as industrial revenues grew relative to the prior quarter as well. As expected, due to factory shutdowns of our customers due to COVID-19, we saw weakness in the automotive end market. In addition, defense was slightly down due to some COVID-19-related component shortages. Overall, the aggregate industrial, medical, defense, automotive market segment was down 3%. Our cloud was slightly down versus the prior quarter. Now please turn to Slide 8. Here you can see, we have a very strong balance sheet. We generated approximately $64 million of cash from operations and $54 million of free cash flow. Cash and cash equivalents were approximately $1.1 billion at the end of the quarter. Again $650 million of our $700 million revolver remain drawn down at the end of the quarter. However, we did not use any of this cash last quarter and do not expect to use any of this cash in the fourth quarter. Again, we generated free cash flow in the third quarter and expect to generate free cash flow again in the fourth quarter. We continue to maintain a low debt-to-cash ratio of 0.9. Our term loan balance has a – our term loan has a balance of $357 million and matures in November 2023. During the quarter, we repurchased approximately 667,000 shares for approximately $17.5 million at an average price of $26.25. For the year to date, we have repurchased a total of approximately 3.4 million shares for a total of approximately $87.6 million at an average price of $25.77. We will continue to be opportunistic in repurchasing shares. I would now ask you to turn to Slide 9. Here you can see additional balance sheet details related to the quarter and the associated comparisons. If we now turn to Slide 10, you can see that inventory was flat at approximately $884 million and inventory turns also flat at 6.9. Cash cycle days were 56.4. Non-GAAP pre-tax return on invested capital was 24.3%, improving from 14.6% last quarter and the best level we’ve seen in many quarters. Now, please turn to Slide 11 so we can discuss the fourth quarter outlook. Our global manufacturing operations in all our geographies are up and running. However, we still foresee continued impact of COVID-19 to our business in the fourth quarter. The impact of COVID-19 and the general macroeconomic environment will continue to evolve as the quarter progresses. Again, as a management team, we will remain focused on the optimization of our cost structure, the leveraging of our existing manufacturing capacity, as well as cash generation. As we think about the outlook, it should be noted that this quarter, we will have 14 weeks relative to 13 weeks in the prior quarter. It should also be noted for year-over-year comparisons, that our fourth quarter does not have 14 weeks every year but once every five years. Our outlook reflects any additional impact of this 14th week on revenues and expenses. Our outlook for the fourth quarter is that revenue will be in the range of $1.73 billion to $1.83 billion. Overall, customer demand for the quarter is expected to be relatively stable in all of our market segments after adjusting for the extra week. We expect non-GAAP gross margins to be in the range of 7.4% to 8%. We expect to see minimal additional benefit related to certain international government subsidies relating to maintaining employment levels in those geographies that we received in the third quarter. Non-GAAP operating expenses should be approximately $61 million to $63 million. The expected increase in operating expenses relative to the prior quarter is primarily the result of the extra week. We expect non-GAAP operating margin to be in the range of 4% to 4.5%. We expect non-GAAP other expenses to be approximately $9 million to $10 million. Our non-GAAP tax rate is expected to be around 18%. We expect non-GAAP fully diluted share count to be approximately 69 million shares. When you consider all of this guidance, our outlook for non-GAAP diluted earnings per share for the quarter is in the range of $0.73 to $0.83. Adjusting for estimated stock compensation of $0.11 per share, that implies GAAP diluted earnings per share is expected to be between $0.62 and $0.72. We expect capital expenditures to be around $18 million and depreciation and amortization to be around $29 million. Finally, again, we expect to generate free cash flow in the quarter. We are intensely focused on every dollar we spend. We will again continue to only spend those dollars we are confident that the return on capital will be compelling. There is a lot of variables that are changing every day as we manage through the COVID-19 crisis and the macroeconomic environment. I believe Sanmina has navigated through these well to-date and we are positioning ourselves well with customers in our key markets to benefit during the ultimate recovery. I will now turn the call back to Hartmut for some additional comments.